NLS Pharmaceutics AG Statistics
Total Valuation
NLSP has a market cap or net worth of $2.43 million. The enterprise value is $3.59 million.
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025, after market close.
Earnings Date | May 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
NLSP has 1.62 million shares outstanding. The number of shares has increased by 29.96% in one year.
Current Share Class | 1.62M |
Shares Outstanding | 1.62M |
Shares Change (YoY) | +29.96% |
Shares Change (QoQ) | +9.87% |
Owned by Insiders (%) | 32.35% |
Owned by Institutions (%) | 4.75% |
Float | 753,146 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | -0.26 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.15
Current Ratio | 0.15 |
Quick Ratio | 0.08 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -27.20 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -227.76% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 96.73% |
Revenue Per Employee | n/a |
Profits Per Employee | -$942,161 |
Employee Count | 7 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.20% in the last 52 weeks. The beta is -0.22, so NLSP's price volatility has been lower than the market average.
Beta (5Y) | -0.22 |
52-Week Price Change | -71.20% |
50-Day Moving Average | 1.64 |
200-Day Moving Average | 3.85 |
Relative Strength Index (RSI) | 49.85 |
Average Volume (20 Days) | 102,798 |
Short Selling Information
The latest short interest is 33,841, so 2.09% of the outstanding shares have been sold short.
Short Interest | 33,841 |
Short Previous Month | 41,768 |
Short % of Shares Out | 2.09% |
Short % of Float | 4.49% |
Short Ratio (days to cover) | 0.97 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -6.31M |
Pretax Income | -12.17M |
Net Income | -6.60M |
EBITDA | -6.30M |
EBIT | -6.31M |
Earnings Per Share (EPS) | -$6.59 |
Full Income Statement Balance Sheet
The company has $552,758 in cash and $1.71 million in debt, giving a net cash position of -$1.16 million or -$0.72 per share.
Cash & Cash Equivalents | 552,758 |
Total Debt | 1.71M |
Net Cash | -1.16M |
Net Cash Per Share | -$0.72 |
Equity (Book Value) | -9.27M |
Book Value Per Share | -9.40 |
Working Capital | -6.53M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -3.92M |
Capital Expenditures | n/a |
Free Cash Flow | -3.92M |
FCF Per Share | -$2.42 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |